VYNE Therapeutics (VYNE) Revenue (2017 - 2026)
VYNE Therapeutics (VYNE) revenue from Mar 31, 2017 to Mar 31, 2026. The TTM VYNE Therapeutics (VYNE) revenue is $440K. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
VYNE Therapeutics (VYNE) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -73.33% |
| 3 Years TTM | -26.92% |
| 5 Years TTM | -61.73% |
| All Time TTM | -35.09% |
Annual Revenue change of VYNE Therapeutics (VYNE)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $90K | -84.21% |
| 2025 | $570K | +14.00% |
| 2024 | $500K | +19.05% |
| 2023 | $420K | -12.50% |
| 2022 | $480K | -48.39% |
| 2021 | $930K | -95.57% |
| 2020 | $21M | +4670.45% |
| 2019 | $440K | -87.78% |
| 2018 | $3.60M | -21.40% |
| 2017 | $4.58M | +583.58% |
| 2016 | $670K | N/A |
| 2015 | $0 | N/A |
Comparison VYNE Therapeutics (VYNE) five years revenue CAGR with competitors
VYNE Therapeutics (VYNE) five years revenue CAGR is -51.74%.